c-Myc tag Peptide: Precision Displacement and Transcription Factor Regulation

Executive Summary: The c-Myc tag Peptide (SKU: A6003, APExBIO) is a synthetic reagent that mimics the C-terminal 410–419 amino acids of human c-Myc, enabling displacement of c-Myc-tagged proteins from anti-c-Myc antibodies in immunoassays [A6003 product page]. This peptide is instrumental for dissecting c-Myc’s role as a proto-oncogenic transcription factor, which regulates cell proliferation, apoptosis, and differentiation [Wu et al., 2021]. Its high aqueous solubility (≥15.7 mg/mL in water with sonication) and specificity make it a critical reagent for research in cancer and gene regulation. The peptide should be stored desiccated at −20°C to maintain stability. It is not intended for diagnostic or clinical use.

Biological Rationale

The c-Myc protein is a key transcription factor encoded by the MYC proto-oncogene. It orchestrates fundamental cellular processes including cell cycle progression, proliferation, differentiation, apoptosis, and stem cell maintenance [Wu et al., 2021]. Aberrant c-Myc expression is implicated in the pathogenesis of many human cancers, with gene amplification or overexpression observed in up to 70% of solid tumors [Wu et al., 2021]. The c-Myc tag Peptide reproduces a specific epitope recognized by anti-c-Myc antibodies, enabling precise interrogation of c-Myc regulatory pathways in vitro [A6003].

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide (sequence: EQKLISEEDL) corresponds to amino acids 410–419 of human c-Myc. It competitively inhibits anti-c-Myc antibody binding by mimicking the antibody’s target epitope [A6003]. When introduced into immunoassays, the peptide displaces c-Myc-tagged fusion proteins from antibody complexes, enabling reversible release and downstream analysis [contrast: expands on specific immunoassay conditions]. This mechanism allows for high specificity and minimal off-target effects, facilitating accurate quantitation and validation of c-Myc protein interactions and function.

Evidence & Benchmarks

• The c-Myc tag Peptide enables displacement of c-Myc-tagged fusion proteins from anti-c-Myc antibodies in vitro, improving immunoassay specificity (APExBIO).
• c-Myc serves as a central regulator of cell proliferation, growth, apoptosis, and differentiation in mammalian cells (Wu et al., 2021).
• The EQKLISEEDL sequence is the canonical myc tag, recognized by multiple commercial monoclonal antibodies (contrast: this article details the displacement mechanism).
• Solubility: ≥60.17 mg/mL in DMSO, ≥15.7 mg/mL in water (with sonication), insoluble in ethanol (APExBIO).
• Storage: Stable when desiccated at −20°C; peptide solutions degrade over prolonged storage (APExBIO).
• c-Myc activation upregulates cyclins and ribosomal biogenesis while downregulating p21 and Bcl-2, facilitating oncogenic transformation (Wu et al., 2021).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is suited for:

• Displacement of c-Myc-tagged fusion proteins from immobilized anti-c-Myc antibodies in immunoprecipitation and ELISA workflows.
• Controls for antibody specificity in protein-protein interaction mapping.
• Studies of transcription factor regulation and c-Myc signaling in cancer models.
• Functional assays exploring proto-oncogene activity and gene amplification.
• Optimization of antibody-based detection and retrieval methods.

This article extends the mechanistic focus of c-Myc tag Peptide: Precision Tools for Gene Regulation by integrating recent autophagy and transcription factor regulation findings relevant to c-Myc’s role in immune modulation.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide does not function as a direct inhibitor of endogenous c-Myc transcription factor activity in living cells.
• It is not suitable for therapeutic or diagnostic applications; intended for in vitro research only (APExBIO).
• Peptide solutions are unstable over long-term storage; always prepare fresh aliquots and store desiccated at −20°C.
• Insoluble in ethanol; do not attempt to dissolve in alcoholic buffers.
• Displacement efficiency depends on antibody affinity and experimental conditions; titration may be required.

Workflow Integration & Parameters

For typical immunoprecipitation or ELISA displacement:

• Dissolve the peptide in DMSO (≥60.17 mg/mL) or water with sonication (≥15.7 mg/mL) for best results.
• Include peptide at a 10- to 100-fold molar excess relative to the c-Myc-tagged protein to ensure effective competition (contrast: this article benchmarks peptide titration strategies).
• Incubate at 4°C to minimize proteolytic degradation; avoid repeated freeze-thaw cycles.
• For antibody validation, use as a negative control to confirm specificity of anti-c-Myc antibody binding.

Conclusion & Outlook

The c-Myc tag Peptide (APExBIO, A6003) is a validated, high-specificity reagent for research on transcription factor regulation and immunoassay optimization. Its efficacy in displacing c-Myc-tagged proteins and inhibiting anti-c-Myc antibody binding is well established. Proper handling and storage are essential for performance. Future advances in cancer biology and gene regulation will further leverage this tool for mechanistic and translational research.